Used in cancer research and therapeutic development, particularly targeting tumor growth and metastasis. This antibody binds specifically to the RON receptor (Recepteur d'Origine Nantais), a tyrosine kinase receptor often overexpressed in epithelial cancers such as breast, colon, pancreatic, and lung cancers. By inhibiting RON signaling, it helps block pathways involved in cell migration, invasion, and survival, making it a valuable tool in studying tumor progression and developing targeted therapies. It has been utilized in preclinical models to evaluate antitumor efficacy and is referenced in the development of biologics aimed at modulating the tumor microenvironment. Its high specificity makes it suitable for immunohistochemistry, flow cytometry, and in vivo functional studies.